---
title: O.C.G.A. § 31-8-307. Referrals to the drug repository program.
collection: code
id: 31-8-307
cite_as: O.C.G.A. § 31-8-307 (2025)
canonical_url: https://georgiacommons.org/code/31-8-307
md_url: https://georgiacommons.org/code/31-8-307.md
text_url: https://georgiacommons.org/code/31-8-307/text
source_url: https://www.legis.ga.gov/api/document/docs/default-source/joint-features-document-library/t31-(v23)-2025-pdf.pdf?sfvrsn=da7ded69_0#page=596
date: 2025
status: active
corpus_version: 2025-supplement-89aa39ab3c68
license: CC0-1.0
publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice.
up: https://georgiacommons.org/code/31-8.md
previous: https://georgiacommons.org/code/31-8-306.md
next: https://georgiacommons.org/code/31-9-1.md
index: https://georgiacommons.org/code/index.md
version: the only printed version
in_force: true
current_through: Including Acts of the 2025 Session of the General Assembly of Georgia
heading_path: HEALTH / CARE AND PROTECTION OF INDIGENT AND ELDERLY PATIENTS / DRUG REPOSITORY PROGRAM
extraction_warnings:
  - dehyphenation_unverified:sustainabil-ity
---

# O.C.G.A. § 31-8-307. Referrals to the drug repository program.

(a) Hospitals and pharmacies licensed in this state and state programs that provide health care coverage or health care services to patients, recipients, or other individuals in this state, including, but not limited to, Medicaid, PeachCare for Kids Program, alcohol and drug awareness programs, and the Department of Corrections, shall provide such patients, recipients, or other individuals with referral information to the program for eligible drugs available through the program for:

(1) Drugs not currently covered under a state program;

(2) Patients who do not meet the eligibility coverage for a state program or become unenrolled or leave a state program;

(3) Drugs that are covered under a state program but are otherwise inaccessible to a patient due to, but not limited to, a gap in coverage or out-of-pocket costs that are too high for a specific patient, recipient, or other individual; a prior authorization requirement; step therapy requirements; or high co-payments; or

(4) A patient, recipient, or other individual for a drug that is covered under a state program but that the claim for coverage is denied with respect to the specific patient, recipient, or other individual.

(b) Recipients of the federal Title X Family Planning Program shall make and document diligent efforts to subcontract with interested eligible recipients participating in the program to offer family planning services to rural and low-income populations.

(c) If an eligible recipient offers value-added services and referrals, in addition to just providing medicine, such eligible recipient may also be eligible for discounted medication pricing to help widen such eligible recipient’s formularies of medication and increase financial sustainability of its participation in the program.

## History

Code 1981, § 31-8-307, enacted by Ga. L. 2024, p. 347, § 2-5/HB 1072, effective April 23, 2024; Ga. L. 2025, p. 1029, § 31(35)/SB 153, effective July 1, 2025.

## Editor's Notes

Ga. L. 2024, p. 347, § 2-1/HB 1072, not codified by the General Assembly, provides: “The General Assembly finds:

“(1) Access to affordable medications is a public health issue that disproportionately impacts vulnerable patients, and a state’s drug repository program can serve as a solution to thousands of families for life-saving and life-preserving medications; and

“(2) Participating recipient organizations can provide a valuable community benefit to families in need by making donated medications available and will be authorized to utilize additional pharmacy technicians to distribute donated medications under the drug repository program.”

## Amendments

The 2025 amendment, effective July 1, 2025, part of an Act to revise, modernize, and correct the Code, revised punctuation in subsection (a) and in paragraph (a)(3).

## Effective Date

This Code section became effective April 23, 2024.